While the pathogenesis of MASLD is complex, many of the associated pathways are related to mTOR, as it is capable of indirectly and directly modulating autophagic activity and lipid accumulation within hepatocytes (24). The gene discussed is MTOR; the disease is metabolic dysfunction-associated steatotic liver disease.